| 86R11548 JSC-D  
---|---  
|  By: Sheffield | H.B. No. 3284  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to prescribing and dispensing controlled substances and  
| monitoring the prescribing and dispensing of controlled substances  
| under the Texas Controlled Substances Act; providing for  
| administrative penalties.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Subchapter C, Chapter 481, Health and Safety  
| Code, is amended by adding Sections 481.0751 and 481.0755 to read as  
| follows:  
|  _Sec._ ___481.0751._ _____DISPENSING VETERINARIANS. (a)_ ___This section_  
| _applies to a veterinarian who holds a registration issued by the_  
| _Federal Drug Enforcement Administration and dispenses Schedule II,_  
| _III, IV, or V controlled substances directly to the owner or handler_  
| _of an animal._  
|  _(b)_ _____Not later than the 30th day after the date the_  
| _veterinarian dispenses a controlled substance, the veterinarian_  
| _shall submit to the board:_  
|  _(1)_ _____the name, strength, and quantity of the substance_  
| _dispensed;_  
|  _(2) the date the substance was dispensed;_  
|  _(3) the name of the animal;_  
|  _(4)_ _____the species, gender, and actual or estimated date_  
| _of birth of the animal;_  
|  _(5) the name and address of the animal's owner; and_  
|  _(6)_ _____the name, address, Federal Drug Enforcement_  
| _Administration number, and telephone number of the veterinarian at_  
| _the veterinarian's usual place of business._  
|  _(c)_ _____A veterinarian shall retain a record of the information_  
| _submitted to the board under Subsection (b) for a period of not less_  
| _than two years after the date the substance is dispensed._  
|  _(d)_ _____Failure to comply with this section is grounds for_  
| _disciplinary action by the State Board of Veterinary Medical_  
| _Examiners._  
|  _Sec._ ___481.0755._ _____WRITTEN, ORAL, AND TELEPHONICALLY_  
| _COMMUNICATED PRESCRIPTIONS. (a) Notwithstanding Sections_  
| _481.073, 481.074, and 481.075, a person prescribing or dispensing a_  
| _controlled substance must use the electronic prescription record_  
| _and may not use a written, oral, or telephonically communicated_  
| _prescription._  
|  _(b)_ _____A prescriber may issue a written, oral, or_  
| _telephonically communicated prescription for a controlled_  
| _substance as authorized under this subchapter only if the_  
| _prescription is issued:_  
|  _(1) by a veterinarian;_  
|  _(2)_ _____in circumstances in which electronic prescribing_  
| _is not available due to temporary technological or electronic_  
| _failure, as prescribed by board rule;_  
|  _(3)_ _____by a practitioner to be dispensed by a pharmacy_  
| _located outside this state, as prescribed by board rule;_  
|  _(4)_ _____when the prescriber and dispenser are the same_  
| _entity;_  
|  _(5)_ _____in circumstances in which necessary elements are_  
| _not supported by the most recent electronic prescription drug_  
| _software;_  
|  _(6)_ _____for a drug for which the United States Food and_  
| _Drug Administration requires additional information in the_  
| _prescription that is not possible with electronic prescribing;_  
|  _(7)_ _____for a non-patient-specific prescription pursuant_  
| _to a standing order, approved protocol for drug therapy,_  
| _collaborative drug management, or comprehensive medication_  
| _management, in response to a public health emergency or in other_  
| _circumstances in which the practitioner may issue a_  
| _non-patient-specific prescription;_  
|  _(8) for a drug under a research protocol;_  
|  _(9)_ _____by a practitioner who has received a waiver under_  
| _Subsection (c) from the requirement to use electronic prescribing;_  
| _or_  
|  _(10)_ _____under circumstances in which the practitioner has_  
| _the present ability to submit an electronic prescription but_  
| _reasonably determines that it would be impractical for the patient_  
| _to obtain the drugs prescribed under the electronic prescription in_  
| _a timely manner and that a delay would adversely impact the_  
| _patient's medical condition._  
|  _(c)_ _____The board shall adopt rules establishing a process by_  
| _which a practitioner may request and receive a waiver under_  
| _Subsection (b)(9), not to exceed one year, from the requirement to_  
| _use electronic prescribing. The board shall adopt rules_  
| _establishing the eligibility for a waiver, including:_  
|  _(1) economic hardship;_  
|  _(2)_ _____technological limitations not reasonably within_  
| _the control of the practitioner; or_  
|  _(3)_ _____other exceptional circumstances demonstrated by_  
| _the practitioner._  
|  _(d)_ _____A written, oral, or telephonically communicated_  
| _prescription must comply with the applicable requirements_  
| _prescribed by Sections 481.074 and 481.075._  
|  _(e)_ _____A dispensing pharmacist who receives a controlled_  
| _substance prescription in a manner other than electronically is not_  
| _required to verify that the prescription is exempt from the_  
| _requirement that it be submitted electronically._  
|  _(f) The board shall enforce this section._  
|  SECTION 2. Sections 481.076(a), (f), (g), and (h), Health  
| and Safety Code, are amended to read as follows:  
|  (a) The board may not permit any person to have access to  
| information submitted to the board under Section 481.074(q) or  
| 481.075 except:  
|  (1) the board, the Texas Medical Board, the Texas  
| _Department of Licensing and Regulation, with respect to the_  
| _regulation of podiatrists_ [ ~~State Board of Podiatric Medical~~  
|  ~~Examiners~~ ], the State Board of Dental Examiners, the State Board of  
| Veterinary Medical Examiners, the Texas Board of Nursing, or the  
| Texas Optometry Board for the purpose of:  
|  (A) investigating a specific license holder; or  
|  (B) monitoring for potentially harmful  
| prescribing or dispensing patterns or practices under Section  
| 481.0762;  
|  (2) an [ ~~authorized officer or member of the department~~  
|  ~~or~~ ] authorized employee of the board engaged in the administration,  
| investigation, or enforcement of this chapter or another law  
| governing illicit drugs in this state or another state;  
|  (3) the department _or other_ [ ~~on behalf of a~~ ] law  
| enforcement or prosecutorial official engaged in the  
| administration, investigation, or enforcement of this chapter or  
| another law governing illicit drugs in this state or another state _,_  
| _if the board is provided a warrant, subpoena, or other court order_  
| _compelling the disclosure_ ;  
|  (4) a medical examiner conducting an investigation;  
|  (5) provided that accessing the information is  
| authorized under the Health Insurance Portability and  
| Accountability Act of 1996 (Pub. L. No. 104-191) and regulations  
| adopted under that Act:  
|  (A) a pharmacist or a pharmacy technician, as  
| defined by Section 551.003, Occupations Code, acting at the  
| direction of a pharmacist; or  
|  (B) a practitioner who:  
|  (i) is a physician, dentist, veterinarian,  
| podiatrist, optometrist, or advanced practice nurse or is a  
| physician assistant described by Section 481.002(39)(D) or an  
| employee or other agent of a practitioner acting at the direction of  
| a practitioner; and  
|  (ii) is inquiring about a recent Schedule  
| II, III, IV, or V prescription history of a particular patient of  
| the practitioner;  
|  (6) a pharmacist or practitioner who is inquiring  
| about the person's own dispensing or prescribing activity; [ ~~or~~ ]  
|  (7) one or more states or an association of states with  
| which the board has an interoperability agreement, as provided by  
| Subsection (j) _; or_  
|  _(8)_ _____a health care facility certified by the federal_  
| _Centers for Medicare and Medicaid Services_.  
|  (f) If the _board accesses_ [ ~~director permits access to~~ ]  
| information under Subsection (a)(2) relating to a person licensed  
| or regulated by an agency listed in Subsection (a)(1), the _board_  
| [ ~~director~~ ] shall notify and cooperate with that agency regarding  
| the disposition of the matter before taking action against the  
| person, unless the _board_ [ ~~director~~ ] determines that notification is  
| reasonably likely to interfere with an administrative or criminal  
| investigation or prosecution.  
|  (g) If the _board provides_ [ ~~director permits~~ ] access to  
| information under Subsection (a)(3) relating to a person licensed  
| or regulated by an agency listed in Subsection (a)(1), the _board_  
| [ ~~director~~ ] shall notify that agency of the disclosure of the  
| information not later than the 10th working day after the date the  
| information is disclosed.  
|  (h) If the _board_ [ ~~director~~ ] withholds notification to an  
| agency under Subsection (f), the _board_ [ ~~director~~ ] shall notify the  
| agency of the disclosure of the information and the reason for  
| withholding notification when the _board_ [ ~~director~~ ] determines that  
| notification is no longer likely to interfere with an  
| administrative or criminal investigation or prosecution.  
|  SECTION 3. Subchapter C, Chapter 481, Health and Safety  
| Code, is amended by adding Sections 481.07635, 481.07655, and  
| 481.0768 to read as follows:  
|  _Sec._ ___481.07635._ _____PRESCRIPTIONS OF OPIOIDS. (a) In this_  
| _section, "acute pain" means pain with abrupt onset that is caused by_  
| _an injury or other process that is not ongoing._  
|  _(b)_ _____For the initial treatment of acute pain, a prescriber_  
| _may not issue a prescription for an opioid in an amount that exceeds_  
| _a 14-day supply._  
|  _Sec._ ___481.07655._ _____LIMITATION OF LIABILITY._ ___(a)_ ___A
prescriber_  
| _or dispenser is not liable in a civil action for damages arising_  
| _from the failure to access prescription drug information as_  
| _required or authorized by Section 481.0764 or failure to submit the_  
| _information to the board as required under Section 481.074(q) or_  
| _481.075, unless the failure constitutes gross negligence or wilful_  
| _misconduct and the prescriber or dispenser would be liable to the_  
| _claimant under other law._  
|  _(b) This section does not establish a standard of care._  
|  _Sec._ ___481.0768._ _____ADMINISTRATIVE PENALTY:_ ___DISCLOSURE OR USE_  
| _OF INFORMATION._ ___(a)_ ___A person authorized to receive information_  
| _under Section 481.076(a) may not disclose or use the information in_  
| _a manner not authorized by this subchapter or other law._  
|  _(b)_ _____A regulatory agency that issues a license,_  
| _certification, or registration to a prescriber or dispenser shall_  
| _periodically update the administrative penalties, or any_  
| _applicable disciplinary guidelines concerning the penalties,_  
| _assessed by that agency for conduct that violates Subsection (a)._  
|  _(c)_ _____The agency shall set the penalties in an amount_  
| _sufficient to deter the conduct._  
|  SECTION 4. Section 481.003(a), Health and Safety Code, is  
| amended to read as follows:  
|  (a) The director may adopt rules to administer and enforce  
| this chapter, other than Sections 481.073, 481.074, 481.075,  
| 481.076, 481.0761, 481.0762, 481.0763, _481.07635,_ 481.0764,  
| 481.0765, _481.07655,_ [ ~~and~~ ] 481.0766 _, and 481.0768_.  The board may  
| adopt rules to administer Sections 481.073, 481.074, 481.075,  
| _481.0751, 481.0755,_ 481.076, 481.0761, 481.0762, 481.0763,  
| _481.07635,_ 481.0764, 481.0765, _481.07655,_ [ ~~and~~ ] 481.0766 _, and_  
| _481.0768_.  
|  SECTION 5. Section 481.128(a), Health and Safety Code, is  
| amended to read as follows:  
|  (a) A registrant or dispenser commits an offense if the  
| registrant or dispenser knowingly:  
|  (1) distributes, delivers, administers, or dispenses  
| a controlled substance in violation of _Subchapter C_ [ ~~Sections~~  
|  ~~481.070-481.075~~ ];  
|  (2) manufactures a controlled substance not  
| authorized by the person's Federal Drug Enforcement Administration  
| registration or distributes or dispenses a controlled substance not  
| authorized by the person's registration to another registrant or  
| other person;  
|  (3) refuses or fails to make, keep, or furnish a  
| record, report, notification, order form, statement, invoice, or  
| information required by this chapter;  
|  (4) prints, manufactures, possesses, or produces an  
| official prescription form without the approval of the board;  
|  (5) delivers or possesses a counterfeit official  
| prescription form;  
|  (6) refuses an entry into a premise for an inspection  
| authorized by this chapter;  
|  (7) refuses or fails to return an official  
| prescription form as required by Section 481.075(k);  
|  (8) refuses or fails to make, keep, or furnish a  
| record, report, notification, order form, statement, invoice, or  
| information required by a rule adopted by the director or the board;  
| or  
|  (9) refuses or fails to maintain security required by  
| this chapter or a rule adopted under this chapter.  
|  SECTION 6. Section 481.129(a), Health and Safety Code, is  
| amended to read as follows:  
|  (a) A person commits an offense if the person knowingly:  
|  (1) distributes as a registrant or dispenser a  
| controlled substance listed in Schedule I or II, unless the person  
| distributes the controlled substance as authorized under the  
| federal Controlled Substances Act (21 U.S.C. Section 801 et seq.);  
|  (2) uses in the course of manufacturing, prescribing,  
| or distributing a controlled substance a Federal Drug Enforcement  
| Administration registration number that is fictitious, revoked,  
| suspended, or issued to another person;  
|  (3) issues a prescription bearing a forged or  
| fictitious signature;  
|  (4) uses a prescription issued to another person to  
| prescribe a Schedule II controlled substance;  
|  (5) possesses, obtains, or attempts to possess or  
| obtain a controlled substance or an increased quantity of a  
| controlled substance:  
|  (A) by misrepresentation, fraud, forgery,  
| deception, or subterfuge;  
|  (B) through use of a fraudulent prescription  
| form; [ ~~or~~ ]  
|  (C) through use of a fraudulent oral or  
| telephonically communicated prescription; or  
|  _(D)_ _____through the use of a fraudulent electronic_  
| _prescription; or_  
|  (6) furnishes false or fraudulent material  
| information in or omits material information from an application,  
| report, record, or other document required to be kept or filed under  
| this chapter.  
|  SECTION 7. Section 554.051(a-1), Occupations Code, is  
| amended to read as follows:  
|  (a-1) The board may adopt rules to administer Sections  
| 481.073, 481.074, 481.075, _481.0751, 481.0755,_ 481.076, 481.0761,  
| 481.0762, 481.0763, _481.07635,_ 481.0764, 481.0765, _481.07655,_  
| [ ~~and~~ ] 481.0766, _and 481.0768,_ Health and Safety Code.  
|  SECTION 8. Section 565.003, Occupations Code, is amended to  
| read as follows:  
|  Sec. 565.003. ADDITIONAL GROUNDS FOR DISCIPLINE REGARDING  
| APPLICANT FOR OR HOLDER OF NONRESIDENT PHARMACY LICENSE. Unless  
| compliance would violate the pharmacy or drug statutes or rules in  
| the state in which the pharmacy is located _,_ the board may discipline  
| an applicant for or the holder of a nonresident pharmacy license if  
| the board finds that the applicant or license holder has failed to  
| comply with:  
|  (1) Section _481.073,_ 481.074 _,_ [ ~~or~~ ] 481.075, _481.0751,_  
| _481.0755, 481.076, 481.0761, 481.0762, 481.0763, 481.07635,_  
| _481.0764, 481.0765, 481.07655, 481.0766, or 481.0768,_ Health and  
| Safety Code;  
|  (2) Texas substitution requirements regarding:  
|  (A) the practitioner's directions concerning  
| generic substitution;  
|  (B) the patient's right to refuse generic  
| substitution; or  
|  (C) notification to the patient of the patient's  
| right to refuse substitution;  
|  (3) any board rule relating to providing drug  
| information to the patient or the patient's agent in written form or  
| by telephone; or  
|  (4) any board rule adopted under Section 554.051(a)  
| and determined by the board to be applicable under Section  
| 554.051(b).  
|  SECTION 9. Sections 481.076(a-3), (a-4), and (a-5), Health  
| and Safety Code, are repealed.  
|  SECTION 10. To the extent of any conflict, this Act prevails  
| over another Act of the 86th Legislature, Regular Session, 2019,  
| relating to nonsubstantive additions to and corrections in enacted  
| codes.  
|  SECTION 11. Section 481.0751, Health and Safety Code, as  
| added by this Act, applies only to a controlled substance dispensed  
| on or after the effective date of this Act.  
|  SECTION 12. Sections 481.0755, 481.07635, and 481.07655,  
| Health and Safety Code, as added by this Act, apply only to a  
| prescription issued on or after the effective date of this Act.  
|  SECTION 13. Section 481.0768(a), Health and Safety Code, as  
| added by this Act, applies only to conduct that occurs on or after  
| the effective date of this Act.  
|  SECTION 14. This Act takes effect September 1, 2019.

